Clinical implications of inflammation in young children (Q33996589)

30 July 2017

1 reference

title

Clinical implications of inflammation in young children (English)

1 reference

30 July 2017

Bush A

1

1 reference

30 July 2017

Tiddens H

series ordinal

2

1 reference

30 July 2017

Silverman M

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

American Journal of Respiratory and Critical Care Medicine

30 July 2017

1 reference

30 July 2017

162

1 reference

30 July 2017

S11-4

1 reference

30 July 2017

2 Pt 2

1 reference

Management of asthma: a consensus statement

30 July 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_1.MAIC-3

How much asthma is really attributable to atopy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_1.MAIC-3

Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_1.MAIC-3

Non-eosinophilic cor ticosteroid unresponsive asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_1.MAIC-3

Use of induced sputum to examine airway inflammation in childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_1.MAIC-3

Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_1.MAIC-3

Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_1.MAIC-3

Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_1.MAIC-3

Lower airway inflammation in infants and young children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_1.MAIC-3

Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_1.MAIC-3

Effect of high-dose ibuprofen in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_1.MAIC-3

Neutrophil apoptosis and clearance from neonatal lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_1.MAIC-3

Earlier identification of biliary atresia and hepatobiliary disease: selective screening in the third week of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_1.MAIC-3

Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_1.MAIC-3

Randomised controlled study of early use of inhaled corticosteroid in preterm infants with respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_1.MAIC-3

Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_1.MAIC-3

Activity of abundant antimicrobials of the human airway

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_1.MAIC-3

CFTR gene transfer reduces the binding of Pseudomonas aeruginosa to cystic fibrosis respiratory epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_1.MAIC-3

Reduction in the adherence of Pseudomonas aeruginosa to native cystic fibrosis epithelium with anti-asialoGM1 antibody and neuraminidase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_1.MAIC-3

Pseudomonas aeruginosa internalization by human epithelial respiratory cells depends on cell differentiation, polarity, and junctional complex integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_1.MAIC-3

Bronchoalveolar Cell Profiles in Children with Asthma, Infantile Wheeze, Chronic Cough, or Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_1.MAIC-3

Controlled Trial of Inhaled Budesonide in Patients with Cystic Fibrosis and Chronic BronchopulmonaryPseudomonas aeruginosaInfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.SUPPLEMENT_1.MAIC-3

10.1164/AJRCCM.162.SUPPLEMENT_1.MAIC-3

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference